Elizabeth F Maughan1,2, Colin R Butler1,2, Claire Crowley2, Gui Zhen Teoh3, Margot den Hondt4, Nicholas J Hamilton1,5, Robert E Hynds1, Peggy Lange6, Tahera Ansari6, Luca Urbani2, Samuel M Janes1, Paolo de Coppi2, Martin A Birchall5, Martin J Elliott7. 1. Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom. 2. Stem Cell and Regenerative Medicine Section, Department of Surgery, UCL Institute of Child Health and Great Ormond Street Children's Hospital, London, United Kingdom. 3. Division of Surgery and Interventional Science, UCL Centre of Nanotechnology and Regenerative Medicine, University College London, Royal Free London NHS Foundation Trust Hospital, London, United Kingdom. 4. Department of Plastic and Reconstructive Surgery, University Hospitals Leuven, Leuven, Belgium. 5. UCL Ear Institute, Royal National Throat, Nose, and Ear Hospital, London, United Kingdom. 6. Northwick Park Institute for Medical Research, Northwick Park, London, United Kingdom. 7. Department of Thoracic Surgery, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.
Abstract
OBJECTIVES/HYPOTHESIS: Despite surgical advances, childhood tracheal stenosis is associated with high morbidity and mortality. Various tracheal scaffold strategies have been developed as the basis for bioengineered substitutes, but there is no consensus on which may be superior in vivo. We hypothesized that there would be no difference in morbidity and mortality between three competing scaffold strategies in rabbits. STUDY DESIGN: Pilot preclinical study. METHODS: Tracheal scaffolds were prepared by three methods that have been applied clinically and reported: preserved cadaveric ("Herberhold") allografts, detergent-enzymatically decellularized allografts, and synthetic scaffolds (nanocomposite polymer [polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU)]). Scaffolds were implanted into cervical trachea of New Zealand White rabbits (n = 4 per group) without cell seeding. Control animals (n = 4) received autotransplanted tracheal segments using the same technique. Animals underwent bronchoscopic monitoring of the grafts for 30 days. Macroscopic evaluation of tissue integration, graft stenosis, and collapsibility and histological examinations were performed on explants at termination. RESULTS: All surgical controls survived to termination without airway compromise. Mild to moderate anastomotic stenosis from granulation tissue was detected, but there was evidence suggestive of vascular reconnection with minimal fibrous encapsulation. In contrast, three of the four animals in the Herberhold and POSS-PCU groups, and all animals receiving decellularized allografts, required early termination due to respiratory distress. Herberhold grafts showed intense inflammatory reactions, anastomotic stenoses, and mucus plugging. Synthetic graft integration and vascularization were poor, whereas decellularized grafts demonstrated malacia and collapse but had features suggestive of vascular connection or revascularization. CONCLUSIONS: There are mirror-image benefits and drawbacks to nonrecellularized, decellularized, and synthetic grafts, such that none emerged as the preferred option. Results from prevascularized and/or cell-seeded grafts (as applied clinically) may elucidate clearer advantages of one scaffold type over another. LEVEL OF EVIDENCE: NA. Laryngoscope, 127:E449-E457, 2017.
OBJECTIVES/HYPOTHESIS: Despite surgical advances, childhood tracheal stenosis is associated with high morbidity and mortality. Various tracheal scaffold strategies have been developed as the basis for bioengineered substitutes, but there is no consensus on which may be superior in vivo. We hypothesized that there would be no difference in morbidity and mortality between three competing scaffold strategies in rabbits. STUDY DESIGN: Pilot preclinical study. METHODS: Tracheal scaffolds were prepared by three methods that have been applied clinically and reported: preserved cadaveric ("Herberhold") allografts, detergent-enzymatically decellularized allografts, and synthetic scaffolds (nanocomposite polymer [polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU)]). Scaffolds were implanted into cervical trachea of New Zealand White rabbits (n = 4 per group) without cell seeding. Control animals (n = 4) received autotransplanted tracheal segments using the same technique. Animals underwent bronchoscopic monitoring of the grafts for 30 days. Macroscopic evaluation of tissue integration, graft stenosis, and collapsibility and histological examinations were performed on explants at termination. RESULTS: All surgical controls survived to termination without airway compromise. Mild to moderate anastomotic stenosis from granulation tissue was detected, but there was evidence suggestive of vascular reconnection with minimal fibrous encapsulation. In contrast, three of the four animals in the Herberhold and POSS-PCU groups, and all animals receiving decellularized allografts, required early termination due to respiratory distress. Herberhold grafts showed intense inflammatory reactions, anastomotic stenoses, and mucus plugging. Synthetic graft integration and vascularization were poor, whereas decellularized grafts demonstrated malacia and collapse but had features suggestive of vascular connection or revascularization. CONCLUSIONS: There are mirror-image benefits and drawbacks to nonrecellularized, decellularized, and synthetic grafts, such that none emerged as the preferred option. Results from prevascularized and/or cell-seeded grafts (as applied clinically) may elucidate clearer advantages of one scaffold type over another. LEVEL OF EVIDENCE: NA. Laryngoscope, 127:E449-E457, 2017.
Authors: Brett E Youngerman; Jennifer A Kosty; Mina M Gerges; Abtin Tabaee; Ashutosh Kacker; Vijay K Anand; Theodore H Schwartz Journal: Acta Neurochir (Wien) Date: 2020-02-11 Impact factor: 2.216
Authors: Victoria Pepper; Cameron A Best; Kaila Buckley; Cynthia Schwartz; Ekene Onwuka; Nakesha King; Audrey White; Sayali Dharmadhikari; Susan D Reynolds; Jed Johnson; Jonathan Grischkan; Christopher K Breuer; Tendy Chiang Journal: Otolaryngol Head Neck Surg Date: 2019-04-30 Impact factor: 3.497
Authors: Anjani Ravindra; William D'Angelo; Li Zhang; Janet Reing; Scott Johnson; Michael Myerburg; Stephen F Badylak Journal: J Surg Res Date: 2021-03-07 Impact factor: 2.417
Authors: Elizabeth F Maughan; Robert E Hynds; Toby J Proctor; Sam M Janes; Martin Elliott; Martin A Birchall; Mark W Lowdell; Paolo De Coppi Journal: Curr Stem Cell Rep Date: 2017-10-26
Authors: Nick J I Hamilton; Robert E Hynds; Kate H C Gowers; Angela Tait; Colin R Butler; Colin Hopper; Alan J Burns; Martin A Birchall; Mark Lowdell; Sam M Janes Journal: Tissue Eng Part C Methods Date: 2019-02 Impact factor: 3.056